Photo: Justin Sullivan/Getty Images

PG&E employees say they are worried about what's at stake for pensions, the health of their 401(k)s and other unpaid obligations from the company as it enters the bankruptcy process.

Details: Though PG&E said it will continue to pay employees' wages, health care and other benefits, many employees expressed major concerns that the company will renegotiate worker contracts in an effort to cut costs. The bankruptcy process is expected to be lengthy and complicated.

Background: PG&E filed for bankruptcy earlier this week, seeking protection on potentially billions of dollars in liability costs for its role in deadly wildfires across California.

Several union members are worried about receiving payments — uncashed paychecks, paid out vacation and severance agreements — owed by the company before it filed for bankruptcy.

  • Employees who received checks more than 180 days before the company filed for bankruptcy, or if they are owed more than $12,850, become creditors in the bankruptcy process — putting total payment of that money at risk since it's paid out after more senior debt holders, as is standard with Chapter 11 bankruptcy protection.

The volatility of PG&E's share price has hit employees' 401(k)s. The stock has rallied in recent days, despite the bankruptcy filing, but has recently fallen as low as $7 from $48 in November, before the deadly Camp fire broke out.

  • "I myself have taken a pretty hefty hit. A significant part of my 401(k) was in PG&E stock," John Mader, who works as an engineer at a PG&E service center and heads the Engineers and Scientists of California (ESC) union, tells Axios. The ESC represents 3,700 of PG&E's 24,000 employees.
  • Analysts are less optimistic employees like Mader will recoup those losses in the near term — analysts' average price target for PG&E by the end of the. year is $14, according to FactSet.

Employees also say they're anxious about whether or not their pensions will be put into play by outside creditors during the bankruptcy process, potentially changing labor agreements, which could impact pension plans and other benefits.

  • IBEW, a union that represents 12,000 PG&E employees, says this prospect is unlikely.
  • In a statement, PG&E spokesperson Paul Doherty tells Axios: "There are no changes to the company's tax-qualified pension plan or life insurance benefits, and the company will continue to make regular pension contributions to that plan as normal."

Go deeper

2 mins ago - World

Nuclear free-for-all: The arms control era may be ending

Illustration: Aïda Amer/Axios

The mushroom clouds over Hiroshima and Nagasaki have remained unreplicated for 75 years in part because the U.S. and Soviet Union — after peering over the ledge into nuclear armageddon — began to negotiate.

Why it matters: The arms control era that began after the Cuban Missile Crisis may now be coming to a close. The next phase could be a nuclear free-for-all.

Pelosi, Schumer demand postmaster general reverse USPS cuts ahead of election

Schumer and Pelosi. Photo: Alex Wong/Getty Images

House Speaker Nancy Pelosi (D-Calif.) and Senate Minority Leader Chuck Schumer sent a letter to Postmaster General Louis DeJoy on Thursday calling for the recent Trump appointee to reverse operational changes to the U.S. Postal Service that "threaten the timely delivery of mail" ahead of the 2020 election.

Why it matters: U.S. mail and election infrastructure are facing a test like no other this November, with a record-breaking number of mail-in ballots expected as Americans attempt to vote in the midst of a pandemic.

2 hours ago - Science

CRISPR co-discoverer on the gene editor's pandemic push

Photo illustration: Aïda Amer/Axios. Photos: Brian Ach/Getty Images for Wired and BSIP/UIG via Getty Images

The coronavirus pandemic is accelerating the development of CRISPR-based tests for detecting disease — and highlighting how gene-editing tools might one day fight pandemics, one of its discoverers, Jennifer Doudna, tells Axios.

Why it matters: Testing shortages and backlogs underscore a need for improved mass testing for COVID-19. Diagnostic tests based on CRISPR — which Doudna and colleagues identified in 2012, ushering in the "CRISPR revolution" in genome editing — are being developed for dengue, Zika and other diseases, but a global pandemic is a proving ground for these tools that hold promise for speed and lower costs.